A Single‐Center, Open‐Label Study on the Use of Injectable Poly‐l‐lactic Acid for the Treatment of Moderate to Severe Scarring from Acne or Varicella

BACKGROUND AND OBJECTIVE Acne scars may negatively impact quality of life. The purpose of this study was to collect preliminary data on the efficacy and safety of injectable poly‐l‐lactic acid (PLLA, Sculptra, Dermik Laboratories) for the treatment of acne scars. METHODS Twenty subjects aged 42.4±10...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic surgery 2007-12, Vol.33, p.S159-S167
1. Verfasser: BEER, KENNETH
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S167
container_issue
container_start_page S159
container_title Dermatologic surgery
container_volume 33
creator BEER, KENNETH
description BACKGROUND AND OBJECTIVE Acne scars may negatively impact quality of life. The purpose of this study was to collect preliminary data on the efficacy and safety of injectable poly‐l‐lactic acid (PLLA, Sculptra, Dermik Laboratories) for the treatment of acne scars. METHODS Twenty subjects aged 42.4±10.7 years (10 men, 10 women) with facial scars resulting from moderate to severe acne or varicella participated in this single‐center, open‐label prospective study. The primary end point was the resolution of the acne or varicella scars. Secondary end points were the physician and subject assessments of scar improvement. PLLA reconstituted with 5 mL of sterile water was injected serially at or near the sites of the acne scars without topical anesthesia. RESULTS Investigator‐assessed reductions in acne scar size and severity were significant (p
doi_str_mv 10.1111/j.1524-4725.2007.33356.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69069414</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69069414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3196-39af4bfc3f4d99187776f26ce6e0621a32d73902cfc6ebc4aa80037cc3d479c53</originalsourceid><addsrcrecordid>eNpFkc1u1DAUhS1ERUvhFZBXrEjqv9jjDdJoyk-lqYqUDlvLca4hoyQeHA90djwCL8DL8SQ40xYsWb7W_c65lg9CmJKS5nWxLWnFRCEUq0pGiCo555Us756gs3-Np7kmShakouwUPZ-mLSGUaU6eoVO6IAtJKnGGfi9x3Y1fevjz89cKxgTxDb7ZwZiva9tAj-u0bw84jDh9BbyZAAePr8YtuGSbHvCn0B8y28_butQ5vHRdi32IR8FtBJuG7DvLrkML0SbAKeAavkMEXDsbY56PfQxDlo7ZP-LPNnYO-t6-QCfe9hO8fDjP0eb9u9vVx2J98-FqtVwXjlMtC66tF4133ItWa7pQSknPpAMJRDJqOWsV14Q57yQ0Tli7IIQr53grlHYVP0ev7313MXzbw5TM0E3HF4wQ9pORmkgtqMjgqwdw3wzQml3sBhsP5vFDM_D2HvjR9XD43ydmDs5szZyPmfMxc3DmGJy5M5f15ljyv8AYkGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69069414</pqid></control><display><type>article</type><title>A Single‐Center, Open‐Label Study on the Use of Injectable Poly‐l‐lactic Acid for the Treatment of Moderate to Severe Scarring from Acne or Varicella</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Journals@Ovid Complete</source><creator>BEER, KENNETH</creator><creatorcontrib>BEER, KENNETH</creatorcontrib><description>BACKGROUND AND OBJECTIVE Acne scars may negatively impact quality of life. The purpose of this study was to collect preliminary data on the efficacy and safety of injectable poly‐l‐lactic acid (PLLA, Sculptra, Dermik Laboratories) for the treatment of acne scars. METHODS Twenty subjects aged 42.4±10.7 years (10 men, 10 women) with facial scars resulting from moderate to severe acne or varicella participated in this single‐center, open‐label prospective study. The primary end point was the resolution of the acne or varicella scars. Secondary end points were the physician and subject assessments of scar improvement. PLLA reconstituted with 5 mL of sterile water was injected serially at or near the sites of the acne scars without topical anesthesia. RESULTS Investigator‐assessed reductions in acne scar size and severity were significant (p&lt;.0001) during the course of seven treatments. Subject‐rated reduction in scar severity was also significant (p=.0078). Subject satisfaction with treatment trended toward an increase with each treatment session and approached significance (p=.0899). Adverse events were limited to depression (n=1) not related to the treatment. CONCLUSION Injectable PLLA as used in this investigation appears to correct the types of acne scars treated in this study without serious adverse effects.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1111/j.1524-4725.2007.33356.x</identifier><identifier>PMID: 18086054</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Acne Vulgaris - complications ; Adult ; Biocompatible Materials - therapeutic use ; Chickenpox - complications ; Cicatrix - drug therapy ; Cicatrix - etiology ; Cosmetic Techniques ; Face ; Female ; Humans ; Injections ; Lactic Acid - therapeutic use ; Male ; Polyesters ; Polymers - therapeutic use ; Prospective Studies ; Quality of Life ; Treatment Outcome</subject><ispartof>Dermatologic surgery, 2007-12, Vol.33, p.S159-S167</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3196-39af4bfc3f4d99187776f26ce6e0621a32d73902cfc6ebc4aa80037cc3d479c53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1524-4725.2007.33356.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1524-4725.2007.33356.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18086054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BEER, KENNETH</creatorcontrib><title>A Single‐Center, Open‐Label Study on the Use of Injectable Poly‐l‐lactic Acid for the Treatment of Moderate to Severe Scarring from Acne or Varicella</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>BACKGROUND AND OBJECTIVE Acne scars may negatively impact quality of life. The purpose of this study was to collect preliminary data on the efficacy and safety of injectable poly‐l‐lactic acid (PLLA, Sculptra, Dermik Laboratories) for the treatment of acne scars. METHODS Twenty subjects aged 42.4±10.7 years (10 men, 10 women) with facial scars resulting from moderate to severe acne or varicella participated in this single‐center, open‐label prospective study. The primary end point was the resolution of the acne or varicella scars. Secondary end points were the physician and subject assessments of scar improvement. PLLA reconstituted with 5 mL of sterile water was injected serially at or near the sites of the acne scars without topical anesthesia. RESULTS Investigator‐assessed reductions in acne scar size and severity were significant (p&lt;.0001) during the course of seven treatments. Subject‐rated reduction in scar severity was also significant (p=.0078). Subject satisfaction with treatment trended toward an increase with each treatment session and approached significance (p=.0899). Adverse events were limited to depression (n=1) not related to the treatment. CONCLUSION Injectable PLLA as used in this investigation appears to correct the types of acne scars treated in this study without serious adverse effects.</description><subject>Acne Vulgaris - complications</subject><subject>Adult</subject><subject>Biocompatible Materials - therapeutic use</subject><subject>Chickenpox - complications</subject><subject>Cicatrix - drug therapy</subject><subject>Cicatrix - etiology</subject><subject>Cosmetic Techniques</subject><subject>Face</subject><subject>Female</subject><subject>Humans</subject><subject>Injections</subject><subject>Lactic Acid - therapeutic use</subject><subject>Male</subject><subject>Polyesters</subject><subject>Polymers - therapeutic use</subject><subject>Prospective Studies</subject><subject>Quality of Life</subject><subject>Treatment Outcome</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc1u1DAUhS1ERUvhFZBXrEjqv9jjDdJoyk-lqYqUDlvLca4hoyQeHA90djwCL8DL8SQ40xYsWb7W_c65lg9CmJKS5nWxLWnFRCEUq0pGiCo555Us756gs3-Np7kmShakouwUPZ-mLSGUaU6eoVO6IAtJKnGGfi9x3Y1fevjz89cKxgTxDb7ZwZiva9tAj-u0bw84jDh9BbyZAAePr8YtuGSbHvCn0B8y28_butQ5vHRdi32IR8FtBJuG7DvLrkML0SbAKeAavkMEXDsbY56PfQxDlo7ZP-LPNnYO-t6-QCfe9hO8fDjP0eb9u9vVx2J98-FqtVwXjlMtC66tF4133ItWa7pQSknPpAMJRDJqOWsV14Q57yQ0Tli7IIQr53grlHYVP0ev7313MXzbw5TM0E3HF4wQ9pORmkgtqMjgqwdw3wzQml3sBhsP5vFDM_D2HvjR9XD43ydmDs5szZyPmfMxc3DmGJy5M5f15ljyv8AYkGw</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>BEER, KENNETH</creator><general>Blackwell Publishing Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200712</creationdate><title>A Single‐Center, Open‐Label Study on the Use of Injectable Poly‐l‐lactic Acid for the Treatment of Moderate to Severe Scarring from Acne or Varicella</title><author>BEER, KENNETH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3196-39af4bfc3f4d99187776f26ce6e0621a32d73902cfc6ebc4aa80037cc3d479c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acne Vulgaris - complications</topic><topic>Adult</topic><topic>Biocompatible Materials - therapeutic use</topic><topic>Chickenpox - complications</topic><topic>Cicatrix - drug therapy</topic><topic>Cicatrix - etiology</topic><topic>Cosmetic Techniques</topic><topic>Face</topic><topic>Female</topic><topic>Humans</topic><topic>Injections</topic><topic>Lactic Acid - therapeutic use</topic><topic>Male</topic><topic>Polyesters</topic><topic>Polymers - therapeutic use</topic><topic>Prospective Studies</topic><topic>Quality of Life</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BEER, KENNETH</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BEER, KENNETH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Single‐Center, Open‐Label Study on the Use of Injectable Poly‐l‐lactic Acid for the Treatment of Moderate to Severe Scarring from Acne or Varicella</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2007-12</date><risdate>2007</risdate><volume>33</volume><spage>S159</spage><epage>S167</epage><pages>S159-S167</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>BACKGROUND AND OBJECTIVE Acne scars may negatively impact quality of life. The purpose of this study was to collect preliminary data on the efficacy and safety of injectable poly‐l‐lactic acid (PLLA, Sculptra, Dermik Laboratories) for the treatment of acne scars. METHODS Twenty subjects aged 42.4±10.7 years (10 men, 10 women) with facial scars resulting from moderate to severe acne or varicella participated in this single‐center, open‐label prospective study. The primary end point was the resolution of the acne or varicella scars. Secondary end points were the physician and subject assessments of scar improvement. PLLA reconstituted with 5 mL of sterile water was injected serially at or near the sites of the acne scars without topical anesthesia. RESULTS Investigator‐assessed reductions in acne scar size and severity were significant (p&lt;.0001) during the course of seven treatments. Subject‐rated reduction in scar severity was also significant (p=.0078). Subject satisfaction with treatment trended toward an increase with each treatment session and approached significance (p=.0899). Adverse events were limited to depression (n=1) not related to the treatment. CONCLUSION Injectable PLLA as used in this investigation appears to correct the types of acne scars treated in this study without serious adverse effects.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>18086054</pmid><doi>10.1111/j.1524-4725.2007.33356.x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-0512
ispartof Dermatologic surgery, 2007-12, Vol.33, p.S159-S167
issn 1076-0512
1524-4725
language eng
recordid cdi_proquest_miscellaneous_69069414
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Journals@Ovid Complete
subjects Acne Vulgaris - complications
Adult
Biocompatible Materials - therapeutic use
Chickenpox - complications
Cicatrix - drug therapy
Cicatrix - etiology
Cosmetic Techniques
Face
Female
Humans
Injections
Lactic Acid - therapeutic use
Male
Polyesters
Polymers - therapeutic use
Prospective Studies
Quality of Life
Treatment Outcome
title A Single‐Center, Open‐Label Study on the Use of Injectable Poly‐l‐lactic Acid for the Treatment of Moderate to Severe Scarring from Acne or Varicella
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A45%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Single%E2%80%90Center,%20Open%E2%80%90Label%20Study%20on%20the%20Use%20of%20Injectable%20Poly%E2%80%90l%E2%80%90lactic%20Acid%20for%20the%20Treatment%20of%20Moderate%20to%20Severe%20Scarring%20from%20Acne%20or%20Varicella&rft.jtitle=Dermatologic%20surgery&rft.au=BEER,%20KENNETH&rft.date=2007-12&rft.volume=33&rft.spage=S159&rft.epage=S167&rft.pages=S159-S167&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1111/j.1524-4725.2007.33356.x&rft_dat=%3Cproquest_pubme%3E69069414%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69069414&rft_id=info:pmid/18086054&rfr_iscdi=true